18Indexed trials
mesh condition
Muscular Dystrophy, Duchenne
Intelligence
Muscular Dystrophy, Duchenne intelligence: 18 indexed trials, 8 recruiting studies, 17 sponsors across 27 countries.
8Recruiting
17Sponsors
27Countries
Leading sponsors
Italfarmaco21 recruiting
Catalyst Pharmaceuticals, Inc.11 recruiting
Catholic University of the Sacred Heart10 recruiting
Copenhagen University Hospital, Rigshospitalet10 recruiting
Institut de Myologie, France11 recruiting
Kevin Flanigan10 recruiting
NS Pharma, Inc.11 recruiting
Nippon Shinyaku Co., Ltd.11 recruiting
PTC Therapeutics10 recruiting
Peking Union Medical College Hospital11 recruiting
Pfizer11 recruiting
Santhera Pharmaceuticals10 recruiting
Geographic activity
United States10trials
Italy8trials
United Kingdom7trials
Belgium7trials
France7trials
Spain7trials
Canada6trials
Germany6trials
Israel5trials
Japan5trials
Australia4trials
Netherlands4trials
Leading interventions
Amondys 451trials
Ataluren1trials
Drisapersen1trials
Exondys 511trials
Flavocoxid1trials
Givinostat1trials
IVR platform trial1trials
Idebenone1trials
NS-050/NCNP-031trials
NS-089/NCNP-021trials
PF-069399261trials
Rituxan treatment1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.